Leap Therapeutics Completes $58.88 Million Cash Private Placement Led by Winklevoss Capital
biotechnology company Leap Therapeutics (NASDAQ stock code: LPTX) announced today that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to launch its digital asset financial strategy. Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy. Under the lead investor agreement, the Leap board of directors will increase to 12 members, Winklevoss Capital will have the right to nominate two individuals to the Leap board of directors, one of whom will also serve as chairman of the board. Morgan, Lewis & Bockius LLP serves as Leap's legal counsel, and Cooley LLP serves as Winklevoss Capital's legal counsel.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Do Kwon Asks Court for 5-Year Prison Cap in Terra Fraud Case
BTC Black Friday: Bitcoin Pumps to $93,000 Before Sharp Pullback
Harmonizing Progress, Earnings, and Environmental Responsibility: Redefining the Modern Corporate Sustainability Formula
- Global corporations are embedding sustainability into operations to meet environmental goals, driven by regulations and investor demands. - HP Inc. and Tesla highlight AI integration and EV cost savings as strategies to balance profitability with carbon reduction. - Energy firms like Eco Wave Power and Core Scientific are advancing renewables and energy-efficient infrastructure amid decarbonization trends. - Challenges persist, including economic pressures and regulatory hurdles, but innovations in finan
Bitcoin Updates: Derivatives Market Confidence Faces Off Against ETF Outflows—Will Bitcoin Reach New All-Time Highs?
- Bitcoin surged to $126,296 in October 2025 via ETF inflows but retreated to $80k amid waning institutional demand and higher rates. - Derivatives activity shows 40x YTD open interest growth, with traders betting on a $120k rebound if $83.5k support holds. - Technical indicators remain mixed: price below 50-day MA and thin order books risk further volatility, but OTC accumulation persists. - Fed policy and ETF flows will determine Bitcoin's path—stabilization near $83.5k or a test of 2025 highs—amid signi
Trending news
MoreCrypto prices
More
